Kambiz Akbari Noghabi | Biological Sciences | Best Researcher Award

Posted on by Neuroscientists

Prof. Dr. Kambiz Akbari Noghabi | Biological Sciences | Best Researcher Award

Prof. Dr. Kambiz Akbari Noghabi, National Institute of Genetic Engineering and Biotechnology (NIGEB), Iran.

Dr. Kambiz Akbari Noghabi is a distinguished microbiologist and biotechnologist whose academic journey began with a Ph.D. in Applied Microbiology-Biotechnology from Gyeongsang National University, South Korea. His pioneering research on cold-induced biopolymers by Pseudomonas fluorescens has been a cornerstone in microbial environmental applications. With a strong foundation in environmental and industrial biotechnology, his research explores the molecular biology of microorganisms, focusing on their potential to address pressing ecological issues.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Kambiz Akbari Noghabi embarked on his academic journey with a deep passion for the microscopic world of microorganisms. He pursued his Ph.D. in Applied Microbiology-Biotechnology at Gyeongsang National University (GNSU), South Korea, from 2003 to 2006. Demonstrating academic excellence, he graduated with an average grade of “A.” His doctoral thesis, entitled “Production of a novel cold-induced biopolymer by Pseudomonas fluorescens BM07; its structural characterization & environmental applications,” not only explored an innovative microbial product but also reflected his dedication to eco-conscious scientific discovery. Recognizing his outstanding capabilities, he was awarded a prestigious BK21 (Brain Korea 21 Program) scholarship—one of South Korea’s most competitive supports for international scholars.

🧫 Research Focus and Scientific Curiosity

Driven by a profound interest in microbial science, Dr. Akbari Noghabi’s research is centered on Environmental and Industrial Biotechnology, with an emphasis on the cellular and molecular biology of microorganisms. His interdisciplinary work spans microbial natural products, environmental microbiology, and bio-nanotechnology. He has continuously explored innovative applications of microbes in solving environmental challenges, demonstrating an exceptional blend of academic rigor and creativity. His research on cold-induced biopolymers remains an example of how basic microbiological insight can inspire sustainable technological advancement.

🔬 Professional Endeavors and Multidisciplinary Integration

Throughout his career, Dr. Akbari Noghabi has collaborated across various disciplines within biological sciences. His scientific curiosity led him to initiate and participate in multidisciplinary projects, which often integrate aspects of biotechnology, molecular biology, and environmental engineering. Whether exploring the behavior of bacteria at the genetic level or developing new methods for environmental cleanup using microbial technologies, he has consistently contributed to the expanding interface between science and society.

🏅 Accolades and Recognition

Recognition has been a natural outcome of Dr. Akbari Noghabi’s relentless pursuit of scientific excellence. His academic merit earned him the highly respected BK21 scholarship during his doctoral studies, acknowledging him as an emerging leader in biotechnology. Beyond this, his work continues to be acknowledged globally through invitations to contribute as a referee for some of the most prestigious scientific journals, affirming the value and credibility of his scientific judgment.

📚 Refereeing Excellence and Scholarly Impact

As a reviewer for an extensive list of world-renowned journals—including Enzyme and Microbial Technology, Bioresource Technology, Scientific Reports, PLoS ONE, and Biotechnology & Bioengineering—Dr. Akbari Noghabi has helped shape the direction of microbial biotechnology research. His engagement with journals from Elsevier, Wiley, Springer, and others reflects not only his subject expertise but also the trust placed in him by the global scientific community to uphold rigorous academic standards and promote impactful research.

🌍 Impact on Science and Society

Dr. Akbari Noghabi’s work carries significant implications for both science and society. His research contributes directly to solving real-world problems, especially in the realm of environmental sustainability. By leveraging microbial capabilities for biopolymer production and environmental remediation, he has provided pathways for cleaner technologies and greener industry practices. His contributions echo in environmental policy discussions, technological innovation, and the academic development of future scientists.

🔮 Legacy and Future Contributions

Looking forward, Dr. Kambiz Akbari Noghabi remains poised to inspire the next generation of biotechnologists and microbiologists. His career is a testament to the power of interdisciplinary science, international collaboration, and persistent curiosity. With a legacy already grounded in scientific integrity and environmental advocacy, his ongoing efforts will undoubtedly continue to shape the future of microbial biotechnology and its applications across sectors.

Publication

  • Title: An efficient biosurfactant-producing bacterium Pseudomonas aeruginosa MR01, isolated from oil excavation areas in south of Iran
    Authors: TB Lotfabad, M Shourian, R Roostaazad, AR Najafabadi, MR Adelzadeh, …
    Year: 2009

 

  • Title: Biosurfactant-producing bacterium, Pseudomonas aeruginosa MA01 isolated from spoiled apples: physicochemical and structural characteristics of isolated biosurfactant
    Authors: H Abbasi, MM Hamedi, TB Lotfabad, HS Zahiri, H Sharafi, F Masoomi, …
    Year: 2012

 

  • Title: Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals
    Authors: F Shahcheraghi, M Abbasalipour, MM Feizabadi, GH Ebrahimipour, …
    Year: 2011

 

  • Title: Structural characterization of a rhamnolipid-type biosurfactant produced by Pseudomonas aeruginosa MR01: enhancement of di-rhamnolipid proportion using gamma irradiation
    Authors: TB Lotfabad, H Abassi, R Ahmadkhaniha, R Roostaazad, F Masoomi, …
    Year: 2010

 

  • Title: Efficient phenol degradation by a newly characterized Pseudomonas sp. SA01 isolated from pharmaceutical wastewaters
    Authors: M Shourian, KA Noghabi, HS Zahiri, T Bagheri, R Karbalaei, M Mollaei, …
    Year: 2009

 

  • Title: Characterization of a chitinase with antifungal activity from a native Serratia marcescens B4A
    Authors: M Zarei, S Aminzadeh, H Zolgharnein, A Safahieh, M Daliri, KA Noghabi, …
    Year: 2011

 

  • Title: A bio-inspired strategy for the synthesis of zinc oxide nanoparticles (ZnO NPs) using the cell extract of cyanobacterium Nostoc sp. EA03: from biological function to toxicity
    Authors: M Ebadi, MR Zolfaghari, SS Aghaei, M Zargar, M Shafiei, HS Zahiri, …
    Year: 2019

 

  • Title: Halophiles and their vast potential in biofuel production
    Authors: MA Amoozegar, A Safarpour, KA Noghabi, T Bakhtiary, A Ventosa
    Year: 2019

 

✅ Conclusion

Dr. Kambiz Akbari Noghabi’s work stands at the intersection of innovation, environmental responsibility, and scientific excellence. Through his research and professional service, he has carved out a lasting legacy in microbial biotechnology. His commitment to advancing the frontiers of science while addressing environmental challenges ensures that his contributions will continue to resonate across generations of researchers and practitioners. Looking ahead, his career promises even greater strides in the pursuit of sustainable, microbe-driven solutions to global problems.

Edyta GLOGOWSKA | Cell Metabolism | Best Researcher Award

Posted on by Neuroscientists

Dr. Edyta Glogowska | Cell Metabolism | Best Researcher Award

Dr.  Edyta Glogowska, CNRS-IPMC-UniCA,  France.

Dr. Edyta Glogowska is a passionate and accomplished biomedical researcher with a strong academic background in biotechnology and life sciences. From her early beginnings in dental engineering to earning a PhD in red blood cell physiology from the University Pierre and Marie Curie, her academic journey reflects a deep commitment to advancing human health through science. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) highlights her expertise in cell physiology, electrophysiology, and molecular biology, with a special focus on macrophage Piezo1 channels and their role in atherosclerosis. She is a skilled communicator and team collaborator, recognized for her academic excellence and contributions to hematology and immunopathology.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Edyta Glogowska’s journey into the world of life sciences began with a strong foundation in biotechnology and medical sciences. She earned her Master of Engineering in Biotechnology Processing from Wroclaw University of Science and Technology, where she graduated with highest honors. Even earlier, she had already laid a unique cornerstone for her biomedical interests through specialized training as a Dental Engineer at the Marie Curie Medical Vocational School. Her pursuit of deeper scientific knowledge led her to France, where she undertook her PhD in Biological and Life Sciences at the University Pierre and Marie Curie, Paris VI. Conducted at the prestigious Station Biologique in Roscoff, her doctoral research focused on red blood cell physiology and was awarded with the highest honors—a testament to her early dedication and scientific promise.

🔬 Professional Endeavors

Dr. Glogowska’s professional career has been marked by a steadfast commitment to cell and molecular biology, electrophysiology, and the biochemistry of proteins. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) in Sophia Antipolis (2021–2024) showcases her hands-on expertise with mice experimentation and patch-clamp techniques, placing her at the cutting edge of biomedical research. Working under the guidance of Dr. Eric Honoré, she explored the role of macrophage Piezo1 channels regulated by lipids, a study with far-reaching implications in understanding and potentially treating atherosclerosis.

🧬 Contributions and Research Focus

Throughout her academic and postdoctoral years, Dr. Glogowska has focused her research on the physiology and pathophysiology of cells, particularly red blood cells and immune cells like macrophages. Her interest lies in understanding how cellular mechanisms contribute to broader medical conditions, such as cardiovascular diseases. By integrating electrophysiology with molecular biology, she brings a comprehensive approach to biomedical questions, bridging the gap between basic research and therapeutic application. Her work on Piezo1 not only contributes to our understanding of mechanotransduction in macrophages but also holds promise for future translational research.

🏅 Accolades and Recognition

Dr. Glogowska’s scholarly excellence has been consistently recognized. She graduated with highest honors both for her Master’s and PhD degrees, a rare academic distinction that underscores her dedication and intellectual rigor. She has also been an active member of the French Society of Hematology, aligning herself with leading experts in her field and staying abreast of the latest developments in blood cell research. These accolades reflect her respected standing within the scientific community.

🌍 Impact and Influence

Beyond technical expertise, Dr. Glogowska is praised for her team coordination and communication skills, qualities that have enabled her to contribute meaningfully to collaborative research environments. Her scientific efforts in understanding lipid–ion channel interactions in macrophages directly influence the broader field of cardiovascular immunology. By elucidating the role of Piezo1 channels in inflammatory processes, her research provides foundational knowledge that can inspire novel pharmacological interventions.

🔎 Legacy and Future Contributions

Dr. Glogowska continues to strive toward a future where her research leads to medical breakthroughs in inflammation and cardiovascular disease. She is particularly interested in translational science, where laboratory discoveries transition into clinical applications. Her strong background in biotechnology, dentistry, and molecular biology uniquely equips her to explore cross-disciplinary challenges in human health. As she advances, she aims to bridge research with clinical solutions, contributing to a legacy of innovation in life sciences.

Publication

Title: Potentiation of macrophage Piezo1 by atherogenic 7-ketocholesterol
Authors: Edyta Glogowska, Gregor P. Jose, Ana Rita Dias Araújo, Laurent Yvan-Charvet, Éric R. Honoré
Year: 2025

Title: Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development
Authors: Fenja Knoepp, Shariq Abid, Amal Houssaïni, Éric R. Honoré, Serge Adnot
Year: 2025

Title: Pharmacological activation of PIEZO1 in human red blood cells prevents Plasmodium falciparum invasion
Authors: Rakhee Lohia, Benoit Allegrini, Laurence Berry, Éric R. Honoré, Kai Wengelnik
Year: 2023

Title: A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes
Authors: Candela Diaz-Canestro, Jiarui Chen, Yan Liu, Michael Andrew Tse, Aimin Xu
Year: 2023

Title: Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects
Authors: Kang Chen, Lai Yee Cheong, Yuan Gao, Hannah Xiaoyan Hui, Aimin Xu
Year: 2022

Title: Author Correction: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: (Correction Published) — Likely 2021 or 2022

Title: Piezo1 and Piezo2 foster mechanical gating of K2P channels
Authors: Edyta Glogowska, Malika Arhatte, Franck C. Chatelain, Amanda Jane Patel, Éric R. Honoré
Year: 2021

Title: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: 2020

Title: Piezo Ion Channels in Cardiovascular Mechanobiology
Authors: Dominique Douguet, Amanda Jane Patel, Aimin Xu, Paul Michel Vanhoutte, Éric R. Honoré
Year: (Not explicitly stated, likely ~2020 based on context)

Title: TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells
Authors: Malika Arhatte, Gihan S. Gunaratne, Charbel El Boustany, Éric R. Honoré, Amanda Jane Patel
Year: 2019

 

 

✅ Conclusion

Driven by curiosity and guided by precision, Dr. Glogowska continues to make meaningful strides in biomedical research. Her work stands at the intersection of basic science and medical application, with the potential to influence future therapeutic strategies for cardiovascular and inflammatory diseases. With her versatile skill set and visionary approach, she is well-positioned to leave a lasting impact on the scientific and medical communities. As she moves forward, Dr. Glogowska aspires to further bridge laboratory discoveries with clinical innovations, fostering a legacy of scientific excellence and translational breakthroughs.

 

Paolo Grumati | Cell Biology | Best Researcher Award

Posted on by Neuroscientists

Prof. Paolo Grumati | Cell Biology | Best Researcher Award

Prof. Paolo Grumati,  TIGEM, Italy.

Dr. Paolo Grumati is a prominent researcher and academic with a focus on molecular biology, particularly the study of autophagy and its role in diseases such as muscular dystrophies and neurodegenerative disorders. His academic journey, beginning with a Master’s and Ph.D. from the University of Padova, laid the foundation for his pioneering work in the molecular mechanisms underlying disease pathogenesis. Dr. Grumati’s professional endeavors have included roles at esteemed institutions like Johann Wolfgang Goethe University and the Telethon Institute of Genetics and Medicine (TIGEM), where he leads groundbreaking research in selective autophagy. His work, which integrates advanced techniques like CRISPR/Cas9, has earned him widespread recognition and numerous accolades, including positions as Associate Professor at the University of Naples. His research has had a significant impact on the scientific community, particularly in the areas of cellular maintenance and therapeutic development.

Profile

Scopus

 

Early Academic Pursuits 🎓


Paolo Grumati’s academic journey began at the University of Padova in Italy, where he pursued a Master’s Degree in Medical Biotechnologies, graduating in 2005. His deep curiosity in the molecular underpinnings of human biology led him to continue his studies with a Ph.D. in Genetic and Molecular Biology, completed between 2006 and 2009. During his Ph.D., he focused on the genetic mechanisms that contribute to various diseases, a pursuit that sparked his lasting interest in molecular biology and disease pathogenesis. His early academic training laid a strong foundation for his future research in the biochemistry of diseases, especially those that affect muscle function and cellular processes.

Professional Endeavors 💼


Dr. Grumati’s professional career has been marked by an impressive trajectory across prestigious institutions. After completing his postdoctoral work on the pathogenesis of muscular dystrophies at the University of Padova, he moved to Germany, where he took a position at the Institute of Biochemistry II at Johann Wolfgang Goethe University. There, between 2013 and 2018, he specialized in the biochemistry and molecular biology of autophagy, a crucial cellular process related to health and disease. His expertise in autophagy became a defining element of his career, and in 2019, he was appointed as the Assistant Investigator and Head of the Mass Spectrometry Core at the Telethon Institute of Genetics and Medicine (TIGEM), where he leads innovative research into the molecular mechanisms of selective autophagy. Throughout these roles, Dr. Grumati has built a reputation for integrating advanced techniques like CRISPR/Cas9 into his work, influencing the field of genetic research.

Contributions and Research Focus 🔬


Dr. Grumati’s research focus has consistently revolved around the intricate molecular processes that govern cellular maintenance and disease, particularly through the lens of autophagy. Since becoming a principal investigator in 2019, his work at TIGEM has concentrated on understanding the molecular mechanisms of selective autophagy, which plays a pivotal role in cellular health and disease. He has pioneered methods to study and manipulate these processes, contributing significantly to the understanding of diseases such as muscular dystrophies and neurodegenerative disorders. His research not only delves into the underlying biology of these conditions but also seeks to identify therapeutic targets that could help manage or even cure these diseases.

Accolades and Recognition 🏆


Dr. Grumati has received widespread recognition for his work in molecular biology and biochemistry. His contributions to the field of autophagy and muscle biology have been honored with leadership roles in prominent research teams, including his time as Team Leader of the Frankfurt CRISPR/Cas9 Screening Center. His excellence in research has earned him a faculty position as Assistant Professor at the University of Naples “Federico II” and an eventual promotion to Associate Professor in 2024. His expertise in mass spectrometry and molecular biology has also made him a sought-after figure in the scientific community, where he is frequently invited to collaborate on interdisciplinary research projects.

Impact and Influence 🌍


Dr. Grumati’s research has had a lasting impact on the scientific community, particularly in the fields of autophagy and muscular dystrophies. His work has influenced both theoretical and applied aspects of molecular biology, from basic research to potential therapeutic interventions. Through his leadership at TIGEM and his involvement in international collaborations, Dr. Grumati has helped to shape the direction of research into autophagy-related diseases. His studies have not only provided insights into the cellular mechanisms at play in these diseases but also paved the way for future therapeutic strategies. He is seen as a key figure in the advancement of precision medicine and molecular therapeutics.

Legacy and Future Contributions 🔮

As Dr. Grumati moves forward in his career, his contributions to the fields of genetics and molecular biology are expected to have a profound and lasting influence. His current work, focusing on selective autophagy, holds promise for the development of novel treatments for diseases that currently have limited therapeutic options. His legacy will likely include innovations in understanding cellular degradation processes and their application to genetic disorders and other diseases. The future of Dr. Grumati’s research will continue to explore the molecular intricacies of human health, offering the potential for breakthroughs in regenerative medicine and disease treatment.

Teaching and Mentorship 👨‍🏫


Beyond his research, Dr. Grumati has made a significant impact through his academic roles at the University of Naples. As an Associate Professor, he plays a key role in shaping the next generation of molecular biologists. His teaching focuses on imparting knowledge in genetics, biochemistry, and molecular biology, with an emphasis on practical research applications. His mentorship has helped guide many students and early-career researchers, who have gone on to make their own contributions to the field. Dr. Grumati’s ability to translate complex scientific concepts into accessible lessons ensures that his influence extends far beyond his own research.

Publication

  • Title: Cortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling
    Authors: M. de Risi, D. Cavezza, G. Torromino, P. Grumati, E. de Leonibus
    Year: 2025

 

  • Title: Two FAM134B isoforms differentially regulate ER dynamics during myogenesis
    Authors: V. Buonomo, K.O. Lohachova, A. Reggio, R.M. Bhaskara, P. Grumati
    Year: 2025

 

  • Title: Ezrin defines TSC complex activation at endosomal compartments through EGFR-AKT signaling
    Authors: G. Giamundo, D. Intartaglia, E. del Prete, R. De Cegli, I. Conte
    Year: 2025

 

  • Title: 3D Rotary Wet-Spinning (RoWS) Biofabrication Directly Affects Proteomic Signature and Myogenic Maturation in Muscle Pericyte–Derived Human Myo-Substitute
    Authors: A. Reggio, C. Fuoco, F. de Paolis, M. Costantini, C. Gargioli
    Year: 2025

 

  • Title: Cross-Linking Mass Spectrometry to Capture Protein Network Dynamics of Cell Membranome
    Authors: L. Santorelli, M. Costanzo, S. Petrosino, M. Ruoppolo, P. Grumati
    Year: 2025

 

  • Title: Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces
    Authors: P. Romani, G. Benedetti, M. Cusan, G. Martello, S. Dupont
    Year: 2024

 

Conclusion


Dr. Paolo Grumati’s career exemplifies the integration of scientific inquiry with practical application, as his research continues to shed light on crucial molecular processes that affect human health. His contributions to the understanding of autophagy have opened new avenues for potential therapeutic strategies in treating genetic disorders and other diseases. As he continues to lead research at TIGEM and teach at the University of Naples, Dr. Grumati’s legacy is set to influence the fields of molecular biology, genetics, and medicine for years to come. His work remains pivotal in advancing both the theoretical understanding of disease mechanisms and the development of new therapeutic approaches, positioning him as a key figure in modern biomedical research.

Manisha Thapliyal | Bioinformatics | Best Researcher Award

Posted on by Neuroscientists

Ms. Manisha Thapliyal | Bioinformatics | Best Researcher Award

Ms. Manisha Thapliyal, Patanjali Research Foundation, India.

Manisha Thapliyal is a dedicated scientist with six years of experience in biotechnology, bioinformatics, and computational drug design. She has led research teams, contributed to groundbreaking studies, and played a key role in developing novel therapeutic solutions. With expertise in plant genetic transformation, nanoparticle synthesis, and large-scale research projects, she is committed to advancing scientific innovation. Her passion for mentoring and organizing scientific events underscores her commitment to fostering future research talent.

Profile

Google Scholar

🌱 Early Academic Pursuits

Manisha Thapliyal’s journey into the world of scientific exploration began with a strong foundation in biotechnology and bioinformatics. Driven by an innate curiosity for life sciences, she pursued higher education with a focus on cutting-edge research methodologies. Her academic endeavors laid the groundwork for her specialization in computational drug design, plant genetic transformation, and nanotechnology. From her early years, she exhibited a passion for interdisciplinary studies, which later became a defining aspect of her professional career.

🧬 Professional Endeavors

With six years of experience in scientific research, Manisha Thapliyal has excelled in leading and managing research teams at the Patanjali Research Foundation in Haridwar. As a Scientist-B, she has guided Assistant Scientists in Computer-Aided Drug Designing (CADD), playing a pivotal role in developing potential therapeutic solutions. Her ability to seamlessly collaborate with bench scientists has ensured that computational strategies align with practical laboratory objectives. Through virtual screenings and molecular analyses, she has significantly contributed to identifying novel drug candidates with promising pharmacological potential.

 

🔬 Contributions and Research Focus

Manisha’s expertise extends across multiple domains, including plant genetic transformation studies, nanoparticle synthesis, and large-scale government-funded research projects. Her interdisciplinary approach bridges computational and experimental research, facilitating innovation in biotechnology. Her technical prowess in bioinformatics has enabled her to decode complex biological datasets, opening new avenues for scientific breakthroughs. Her research contributions are not limited to publications but extend to mentoring young scientists and fostering research-driven environments.

🏆 Accolades and Recognition

Recognized for her dedication and innovation in scientific research, Manisha has played a crucial role in several high-impact studies and book chapters. Her ability to integrate computational tools with experimental frameworks has earned her acclaim within the research community. She has been instrumental in organizing national and international conferences, workshops, and training programs, further solidifying her role as a thought leader in the field of biotechnology

🌍 Impact and Influence

Beyond her technical contributions, Manisha has been an active mentor, shaping the careers of aspiring researchers and young scientists. Her leadership in capacity-building initiatives has empowered the next generation of scientists to develop skills in drug discovery, genetic engineering, and bioinformatics. By fostering collaborative research environments, she has ensured that scientific advancements translate into meaningful healthcare and biotechnological solutions.

🔮 Legacy and Future Contributions

With an unwavering commitment to scientific excellence, Manisha Thapliyal envisions a future where biotechnology continues to drive innovation in medicine and environmental sustainability. Her focus remains on leveraging computational intelligence for precision drug discovery and sustainable biotechnological applications. As she advances in her career, she aims to expand her research horizon, bridging the gap between theoretical insights and real-world applications, ultimately contributing to the global scientific community.

Publication

  • SCREENING AND ISOLATION OF ANTIBACTERIAL PROTEINS/PEPTIDES FROM SEEDS OF MILLETS
    Authors: Anjali Bisht, Manisha Thapliyal
    Year: 2016

 

  • ISOLATION OF ANTIBACTERIAL PROTEIN/PEPTIDE FROM FICUS GLOMERATA LEAF
    Authors: Manisha Thapliyal, Anjali Bisht
    Year: 2016

 

  • Current Status of Indian Agriculture: Problems, Challenges and Solution
    Authors: Acharya Balkrishna, Manisha Phour
    Year: 2021

 

  • Role of AP2/EREBP Transcription Factor Family in Environmental Stress Tolerance
    Authors: Anjali Pande, Saurabh C Saxena, Manisha Thapliyal, Sudhir K Guru, Atul Kumar
    Year: 2018

 

  • Unraveling the therapeutic potential of Senna singueana phytochemicals to attenuate pancreatic cancer using protein–protein interactions, molecular docking, and …
    Authors: Acharya Balkrishna, D Sharma, M Thapliyal, V Arya, A Dabas
    Year: 2023

 

  • Isolation and Identification of α- Amylase activity Inhibiting compounds from Bryophyllum Pinnatum
    Authors: S R Kumar, M Thapliyal, A Singh
    Year: 2016

 

🏁 Conclusion

Manisha Thapliyal stands as a beacon of inspiration in the ever-evolving field of biotechnology. Her relentless pursuit of scientific excellence, coupled with her leadership in research and mentorship, has positioned her as a key contributor to scientific progress. Through her continued efforts in biotechnology and bioinformatics, she is set to make lasting contributions that will shape the future of drug discovery and sustainable scientific solutions.

 

Soumya Basu | miRNA Biology | Excellence Award (Any Scientific field)

Posted on by Neuroscientists

Dr. Soumya Basu | miRNA Biology | Excellence Award (Any Scientific field)

Dr. Soumya Basu, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute,  India.

Dr. Soumya Basu is a distinguished scientist and academic specializing in cancer and translational research. With a Ph.D. in Life Sciences and over 18 years of research experience, he has made significant contributions to understanding drug-resistant cancer and targeted therapies. His academic journey spans multiple disciplines, including microbiology, medical writing, and artificial intelligence applications in cancer research. As an Associate Professor at Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, he has played a pivotal role in scientific mentorship, research advancements, and cross-disciplinary collaborations. His expertise in molecular oncology, cell-based assays, and small molecule design has led to impactful research, widely recognized in the scientific community through publications and citations.

 

Profile

Google Scholar

 

Early Academic Pursuits 🎓

From an early stage, Dr. Soumya Basu exhibited a keen interest in the sciences, embarking on an academic journey that laid the foundation for an illustrious career in life sciences and cancer research. He earned a Bachelor of Science in Physics, Chemistry, and Mathematics from the University of Burdwan, followed by a Master’s degree in Microbiology from the University of Kalyani. His unwavering passion for research led him to pursue a Ph.D. in Life Sciences at Jadavpur University, focusing on reactive oxygen species-mediated targeted therapy in drug-resistant cancer. Further enhancing his expertise, he pursued an Advanced Diploma in Medical Writing and Regulatory Affairs and later completed an Advanced Postgraduate course in Artificial Intelligence and Machine Learning from the University of Texas at Austin, reinforcing his multidisciplinary approach to modern scientific research.

Professional Endeavors 🎮

Dr. Basu’s professional journey is marked by his dedication to academia and translational research. He currently serves as an Associate Professor and Principal Investigator at the Cancer and Translational Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Pune. His tenure at Dr. D. Y. Patil Vidyapeeth spans over a decade, where he initially joined as an Assistant Professor before rising to his current role. Prior to this, he contributed significantly as a Research Associate at the Molecular Functional Imaging Laboratory, ACTREC, Tata Memorial Center, and held esteemed positions as a Senior Research Fellow at the Chittaranjan National Cancer Institute (CNCI) and a Project Assistant at Jadavpur University and the University of Calcutta. His early teaching career at Kulti College further highlights his commitment to education and mentorship.

Contributions and Research Focus 🧑‍�‍🔬

Dr. Basu’s research is deeply rooted in cancer therapeutics, particularly in drug-resistant malignancies. His work spans multiple domains, including animal cell culture, cell-based assays, small molecule design and validation, and non-coding RNA research. With a strong emphasis on translational research, he has been at the forefront of developing novel therapeutic strategies targeting drug-resistant cancer cells. His contributions to molecular oncology and biotechnology have paved the way for advancements in personalized medicine, integrating computational approaches like artificial intelligence and machine learning to enhance predictive models in cancer treatment.

Accolades and Recognition 🏆

Over his distinguished career, Dr. Basu has garnered widespread recognition for his contributions to scientific research. His prolific publication record, including books, book chapters, research articles, and technical reports, attests to his commitment to advancing knowledge in cancer biology. His Google Scholar profile boasts an H-index of 14, with over 550 citations, underscoring the impact of his research in the global scientific community. His expertise in scientific writing and editing has also made him a sought-after mentor and collaborator in academia.

Impact and Influence 📈

Dr. Basu’s work has had a profound impact on the field of oncology, with his research findings influencing therapeutic strategies and treatment paradigms. His mentorship and guidance have inspired numerous young researchers, fostering the next generation of scientists dedicated to battling cancer. His contributions extend beyond the laboratory, as he actively participates in knowledge dissemination through conferences, workshops, and academic collaborations. His ability to bridge the gap between fundamental research and clinical application has positioned him as a thought leader in the field.

Legacy and Future Contributions 🌟

As a scientist and educator, Dr. Basu’s legacy is defined by his relentless pursuit of innovation in cancer research. His ongoing work aims to refine targeted therapies, explore novel drug delivery systems, and harness artificial intelligence for more effective cancer diagnostics and treatment. With a vision to create a lasting impact on cancer care, he continues to drive transformative research initiatives. His unwavering commitment to scientific excellence ensures that his contributions will shape the future of oncology for years to come.

 

Publication

  1. Synthesis, spectroscopic characterization, X-ray powder structure analysis, DFT study and in vitro anticancer activity of N-(2-methoxyphenyl)-3-methoxysalicylaldimine

    • Authors: B Chattopadhyay, S Basu, P Chakraborty, SK Choudhuri, AK Mukherjee, …
    • Year: 2009

 

  1. Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate

    • Authors: A Ganguly, S Basu, P Chakraborty, S Chatterjee, A Sarkar, M Chatterjee, …
    • Year: 2010

 

  1. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach

    • Authors: KB Lokhande, S Ballav, RS Yadav, KV Swamy, S Basu
    • Year: 2022

 

  1. Use of BRET to study protein–protein interactions in vitro and in vivo

    • Authors: S Dimri, S Basu, A De
    • Year: 2016

 

  1. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis

    • Authors: A Ganguly, S Basu, K Banerjee, P Chakraborty, A Sarkar, M Chatterjee, …
    • Year: 2011

 

  1. PPAR-γ partial agonists in disease-fate decision with special reference to cancer

    • Authors: S Ballav, B Biswas, VK Sahu, A Ranjan, S Basu
    • Year: 2022

 

  1. Drug repurposing—an emerging strategy in cancer therapeutics

    • Authors: JA Khadija Shahab Turabi, Ankita Deshmukh, Sayan Paul, Dayanand Swami, S Basu
    • Year: 2022

 

  1. Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule study

    • Authors: KB Lokhande, S Ballav, N Thosar, KV Swamy, S Basu
    • Year: 2020

 

Conclusion 🌟

Dr. Soumya Basu’s career is a testament to his unwavering dedication to cancer research and academia. His contributions to targeted therapies, translational oncology, and biomedical advancements continue to influence both scientific understanding and clinical applications. Through his mentorship and research initiatives, he is shaping the next generation of scientists while driving forward innovative solutions for cancer treatment. With his ongoing efforts in integrating AI with biomedical sciences, Dr. Basu remains at the forefront of cutting-edge cancer research, ensuring a lasting impact on the field.

 

 

 

 

Vikash Kumar | Molecular Biology | Best Researcher Award

Posted on by Neuroscientists

Dr. Vikash Kumar | Molecular Biology | Best Researcher Award

Dr. Vikash Kumar, Central Inland Fisheries Research Institute,  India.

Dr. Vikash Kumar is a distinguished scientist in the field of aquaculture and fish health management, with over 15 years of research experience. His academic journey, from earning a Ph.D. with distinction at Ghent University to holding key research positions at ICAR-CIFRI, has been marked by excellence. His expertise spans transcriptomics, proteomics, cellular biology, and immunohistochemistry, with a strong focus on understanding fish and shrimp immunological responses. His groundbreaking research on Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp and inflammation in Labeo rohita has significantly contributed to disease mitigation strategies in aquaculture. Recognized among the Top 2% of Scientists globally (Stanford/Elsevier, 2024), Dr. Kumar’s influence extends beyond research, shaping policies and fostering international collaboration.

profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Vikash Kumar’s journey into the world of aquaculture and fish health began with a strong academic foundation. With a Bachelor of Fisheries Science from the College of Fisheries, India, he excelled in his studies, earning first-class distinction with an impressive 8.66/10.0 GPA. Building upon this, he pursued a Master of Fisheries Science in Fish Health from ICAR-Central Institute of Fisheries Education (CIFE), India, where he once again showcased academic brilliance, securing an 8.23/10.0 GPA. His thirst for knowledge and dedication to research led him to Belgium, where he earned his Ph.D. from the esteemed Laboratory of Aquaculture & Artemia Reference Center, Ghent University, in 2020. Awarded with distinction, his doctoral studies solidified his expertise in fish and shrimp immunology, setting the stage for a remarkable scientific career.

🏅 Professional Endeavors

With more than 15 years of experience in aquaculture and fish health management, Dr. Kumar has made significant strides in his field. His professional journey began in 2014 as a Scientist at the ICAR-Central Inland Fisheries Research Institute (ICAR-CIFRI) in Kolkata, India. After four years of dedicated service, he embarked on his doctoral research at Ghent University, where he explored critical aspects of aquatic immunology. Returning to ICAR-CIFRI in 2020 as a Senior Scientist, he continues to contribute to the advancement of fisheries research, working with diverse stakeholders and scientists to address pressing challenges in the aquaculture industry.

🔬 Contributions and Research Focus

Dr. Kumar’s research spans a broad spectrum of critical topics in aquaculture. His expertise in transcriptomics, proteomics, cellular biology, histology, immunohistochemistry, and electron microscopy has enabled him to unravel complex immunological responses in fish and shrimp. His work has provided invaluable insights into the virulence and pathogenesis of Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp, leading to the development of innovative mitigation strategies. Additionally, his research on carrageenan-induced inflammation in Labeo rohita has contributed to a deeper understanding of fish immune responses, paving the way for improved disease management in aquaculture.

🏆 Accolades and Recognition

Dr. Kumar’s contributions to fisheries science have earned him global recognition. He is ranked among the Top 2% of Scientists worldwide as per Stanford/Elsevier rankings in 2024, a testament to his impactful research and scientific excellence. His work is widely acknowledged in the scientific community, reflecting his dedication to enhancing the health and sustainability of aquatic species. His commitment to continuous learning and innovation has made him a respected figure in fisheries research, both in India and internationally.

🌍 Impact and Influence

Dr. Kumar’s research has significantly influenced disease management strategies in aquaculture, directly benefiting the fisheries industry. His work has helped improve diagnostic methods, develop novel treatment approaches, and enhance the overall resilience of aquaculture systems against infectious diseases. His ability to collaborate with researchers worldwide has fostered the exchange of knowledge, strengthening the global scientific network dedicated to sustainable aquaculture practices.

🔬 Legacy and Future Contributions

As a dedicated scientist, Dr. Kumar’s legacy is defined by his relentless pursuit of solutions for aquaculture challenges. His research continues to inspire young scientists, and his contributions are shaping the future of fish health management. Moving forward, he aims to expand his studies on disease mitigation strategies, explore cutting-edge biotechnological approaches, and contribute to policy frameworks that promote sustainable fisheries. His unwavering commitment to scientific advancement ensures that his impact will resonate for generations to come.Dr. Vikash Kumar stands as a beacon of excellence in aquaculture research, transforming the field with his expertise, passion, and vision for a healthier aquatic future.

publication

  • Genus Bacillus, Promising Probiotics in Aquaculture: Aquatic Animal Origin, Bio-Active Components, Bioremediation and Efficacy in Fish and Shellfish
    Authors: M Soltani, K Ghosh, SH Hoseinifar, V Kumar, AJ Lymbery, S Roy, E Ringø
    Year: 2019

 

  • Application of Probiotics in Shrimp Aquaculture: Importance, Mechanisms of Action, and Methods of Administration
    Authors: V Kumar, S Roy, DK Meena, UK Sarkar
    Year: 2016

 

  • Acute Hepatopancreatic Necrosis Disease (AHPND): Virulence, Pathogenesis and Mitigation Strategies in Shrimp Aquaculture
    Authors: V Kumar, S Roy, BK Behera, P Bossier, BK Das
    Year: 2021

 

  • Immunostimulants for Aquaculture Health Management
    Authors: D Barman, P Nen, SC Mandal, V Kumar
    Year: 2013

 

  • A Practical Approach on SDS PAGE for Separation of Protein
    Authors: S Roy, V Kumar
    Year: 2014

 

  • Phloroglucinol-Mediated Hsp70 Production in Crustaceans: Protection Against Vibrio Parahaemolyticus in Artemia Franciscana and Macrobrachium Rosenbergii
    Authors: V Kumar, K Baruah, DV Nguyen, G Smagghe, E Vossen, P Bossier
    Year: 2018

 

  • Biofloc Microbiome with Bioremediation and Health Benefits
    Authors: V Kumar, S Roy, BK Behera, BK Das
    Year: 2021

 

  • Acute Phase Proteins and Their Potential Role as an Indicator for Fish Health and in Diagnosis of Fish Diseases
    Authors: S Roy, V Kumar, V Kumar, BK Behera
    Year: 2017

 

Conclusion

Dr. Vikash Kumar’s contributions to aquaculture science are both profound and far-reaching. His work not only advances scientific understanding but also provides practical solutions for the sustainable growth of the fisheries industry. His dedication to innovation, research, and global collaboration cements his status as a leading scientist in his field. As he continues his pursuit of excellence, his impact on aquatic health management will undoubtedly shape the future of sustainable aquaculture and inspire upcoming generations of researchers. 🌊🐠

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

 

Profile

Scopus

 

🎓 Early Academic Pursuits

Pongrama Ramasoota’s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

🏥 Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

🦠 Contributions and Research Focus

Dr. Ramasoota’s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

🏆 Accolades and Recognition

Dr. Ramasoota’s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailand’s Outstanding Researcher in 2020 and named Thailand’s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventors’ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

🌍 Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasoota’s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

📚 Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

  1. Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
    Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
    Year: 2024

 

  1. Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
    Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
    Year: 2024

 

  1. Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
    Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
    Year: 2024

 

  1. Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
    Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
    Year: 2023

 

  1. Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
    Year: 2023

 

  1. Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
    Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
    Year: 2022

 

  1. Title: Spread of a Novel Indian Ocean Lineage Carrying E1‐K211E/E2‐V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
    Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
    Year: 2022

 

🎯 Conclusion

Dr. Ramasoota’s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.

 

Dinh Phong Son | CircRNA | Best Researcher Award

Posted on by Neuroscientists

Dr. Dinh Phong Son | CircRNA | Best Researcher Award

Dr. DINH PHONG SON, DUYTAN UNIVERSITY, Vietnam.

Dr. Dinh Phong Son is a researcher specializing in laboratory medicine techniques with a Ph.D. in Molecular Medicine from Guangxi Medical University, China. His research focuses on modern molecular biology techniques, particularly the identification of potential biomarkers for early disease diagnosis and targeted therapy. His studies explore systemic diseases such as diabetes, cardiovascular diseases, and cancer, emphasizing gene editing technologies like CRISPR/Cas9. His recent publications contribute to the understanding of regulatory RNA networks and their implications in disease mechanisms, providing a foundation for future studies on molecular interactions and targeted drug development.

Profile

Orcid

 

🎓 Early Academic Pursuits

From the very beginning of my academic journey, I was deeply fascinated by the intricate mechanisms of life at a molecular level. My pursuit of knowledge led me to study Laboratory Medicine Technique at Hue University of Medicine and Pharmacy, Vietnam, where I honed my expertise in diagnostic methodologies and medical laboratory sciences. With an insatiable thirst for discovery, I furthered my education by earning a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China. This academic foundation set the stage for my dedication to the field of molecular biology, shaping my vision to explore genetic markers and innovative diagnostic tools.

👩‍🎓 Professional Endeavors

Currently, I serve at Duy Tan University, College of Medicine and Pharmacy, where I actively contribute to research, mentoring, and academic discourse. My work primarily revolves around molecular diagnostics, genetic analysis, and disease biomarker identification, aiming to bridge the gap between molecular biology and clinical applications. With advancements in next-generation sequencing (NGS) and bioinformatics databases, I continually seek new pathways to enhance the precision of disease detection and treatment strategies.

🧪 Contributions and Research Focus

My research is deeply rooted in molecular medicine, focusing on the identification of potential biomarkers for the early diagnosis of systemic diseases such as diabetes, cardiovascular diseases, stroke, and cancer. My investigations also extend to exploring gene targets for pharmacological studies, assisting in drug development through the modulation of gene expression using cutting-edge technologies like CRISPR/Cas9, gene overexpression, and silencing approaches. Furthermore, my work delves into the complex LncRNA/CircRNA/miRNA/gene/protein-drug interaction networks, paving the way for theoretical models that could revolutionize targeted therapy research.

 

💎 Impact and Influence

The impact of my research extends beyond academia, as it plays a crucial role in early disease screening, personalized medicine, and therapeutic advancements. By leveraging molecular networks, I aim to facilitate the development of precise diagnostic tools and gene-targeted interventions, significantly improving patient outcomes. My research findings have the potential to reshape biomedical applications and create avenues for innovative treatment strategies across various diseases.

🌟 Legacy and Future Contributions

Looking ahead, my aspirations remain steadfast in expanding molecular biology research, particularly in uncovering novel biomarkers and refining gene-editing techniques. As the field continues to evolve, I hope to contribute to the refinement of therapeutic gene modifications and biomarker-based diagnostics. With sustained efforts and collaborations, I envision a future where my research serves as a cornerstone for breakthroughs in precision medicine, targeted gene therapy, and advanced molecular diagnostics.

👨‍💼 Professional Collaborations and Memberships

As an active member of the scientific community, I engage in collaborations and professional affiliations to foster knowledge exchange and multidisciplinary research. My involvement in editorial appointments, consultancy projects, and industry partnerships enables me to extend my research impact, ensuring that molecular medicine continues to advance for the benefit of humanity.

 

Publication

  • Title: Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on Microarray Data analysis, molecular docking, and dynamic simulation
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Hai-Anh Ha, Aigul Utegenova, Awais Ali, Abdulaziz Alamri
    Year: 2025

 

  • Title: Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Awais Ali, ShangLing Pan
    Year: 2024

 

  • Title: Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data
    Authors: ChauMyThanh Tran, PhongSon Dinh
    Year: 2024

 

  • Title: Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease
    Authors: PhongSon Dinh, JunHua Peng, ThanhLoan Tran, DongFeng Wu, ChauMyThanh Tran, ThiPhuongHoai Dinh, ShangLing Pan
    Year: 2023

 

  • Title: Construction of miRNAs and gene expression profiles associated with ischemic cardiomyopathy: Bioinformatics analysis
    Authors: PhongSon Dinh, Jun-Hua Peng, ChauMyThanh Tran, ThanhLoan Tran, Shang-Ling Pan
    Year: 2022

 

Conclusion

Dr. Son’s research plays a crucial role in advancing molecular biology by identifying key biomarkers and regulatory networks for disease screening and treatment. His work in gene-targeted therapy and RNA interaction networks lays the groundwork for future innovations in precision medicine. Despite challenges in resources and time, his commitment to molecular research aims to drive further advancements in understanding and treating complex diseases.

Kawthar Diab | Life Science | Best Researcher Award

Posted on by Neuroscientists

Kawthar Diab | Life Science | Best Researcher Award

Prof. Dr. Kawthar Diab, National Research Centre, Egypt.

Dr. Kawthar Abdelaziz Elsayed Mohamed Diab is a distinguished Research Professor in Genetics and Cytology at the National Research Centre, Cairo, Egypt. With a strong foundation in zoology, she pursued advanced degrees focusing on genotoxicity, cytogenetics, and medicinal plant applications in disease prevention. Her postdoctoral research at Tokai University, Japan, and the Indian Institute of Integrative Medicine, India, expanded her expertise in cancer pharmacology and bioscience. Dr. Diab has made significant contributions to genetic toxicology and the chemopreventive properties of medicinal plants, with a particular focus on the Lamiaceae family and Himalayan plants. She actively mentors Ph.D. students and collaborates on groundbreaking research projects, gaining international recognition through conferences and workshops.

Profile

Google Scholar

Scopus

🌱 Early Academic Pursuits

Kawthar Abdelaziz Elsayed Mohamed Diab embarked on her academic journey with a deep passion for zoology, earning her B.Sc. in Zoology from Al-Azhar University in 1996 with a distinguished grade of “Very Good.” She further honed her expertise by obtaining an M.Sc. in Experimental Zoology from Zagazig University in 2003, where she conducted cytogenetic and immunogenetic studies on the effects of chemotherapy drugs on reproduction. Her academic curiosity and dedication led her to pursue a Ph.D. in Zoology at Ain Shams University, awarded in 2009. Her doctoral research focused on the protective effects of medicinal plants against genotoxic damage induced by hydrocortisone in mice, marking the beginning of her lifelong commitment to genetic research and cytology.

🧬 Professional Endeavors

As a Research Professor at the Genetics and Cytology Department of the National Research Centre in Cairo, Egypt, Dr. Kawthar Diab has played a pivotal role in advancing genetic studies. Her postdoctoral fellowships further expanded her scientific horizons—first in Cancer Pharmacology at the Indian Institute of Integrative Medicine in 2012 and later in Bioscience at Tokai University, Japan, in 2014. These international research experiences enriched her expertise in genetic applications, cytogenetics, and pharmacogenomics. Her relentless pursuit of knowledge has positioned her as a leading researcher in genetic and cytological studies, bridging traditional knowledge with cutting-edge scientific advancements.

🌿 Contributions and Research Focus

Dr. Diab’s research delves into the genotoxicity of pharmaceutical compounds and the protective effects of medicinal plants. Her investigations focus on the genetic impact of chemotherapy drugs and natural therapeutic agents, particularly those derived from the Lamiaceae family, known for their biochemical and therapeutic properties. Her recent supervision of Ph.D. research on biochemical and therapeutic evaluations of medicinal plants for prostate diseases underscores her commitment to integrating molecular genetics with natural medicine. Additionally, her work on cancer chemoprevention using Himalayan plants has gained international recognition, reflecting her dedication to discovering novel plant-based remedies for serious health conditions.

🌍 Accolades and Recognition

Dr. Kawthar Diab’s expertise has been acknowledged on the global stage. She was invited as a speaker at the 6th Rajabhat University National and International Research and Academic Conference (2020), where she presented her groundbreaking research on cancer chemopreventive activity of Himalayan plants. She has also participated in esteemed international workshops, including the Fluorescence Microscopy Workshop at ICGEB, New Delhi (2019), further enhancing her methodological skills. These recognitions highlight her contributions to genetic research and her growing influence in the scientific community.

📖 Impact and Influence

Beyond her research, Dr. Diab is actively shaping the next generation of scientists. She mentors young researchers, including Ph.D. students working on innovative projects in pharmacogenomics and plant-based medicine. Her collaboration with interdisciplinary teams ensures that her work extends beyond academic publications, making real-world contributions to medical science and genetics. By fostering a culture of inquiry and scientific exploration, she continues to inspire budding researchers to explore the genetic foundations of disease prevention and treatment.

🔬 Legacy and Future Contributions

With a research portfolio spanning genetic toxicology, medicinal plant applications, and cytogenetics, Dr. Kawthar Diab’s legacy is firmly established in the scientific world. She envisions a future where genetic research and plant-based therapeutics converge to provide safer, more effective treatments for cancer and genetic disorders. Her continuous engagement with international scientific platforms and her mentorship of emerging scholars ensure that her influence will extend far beyond her own research, shaping the future of genetic and cytological studies.

Publication

  • Title: In Vitro Anticancer Activities of Anogeissus latifolia, Terminalia bellerica, Acacia catechu and Moringa oleifera Indian Plants
    Author: KAE Diab, SK Guru, S Bhushan, AK Saxena
    Year: 2015

 

  • Title: In vitro studies on phytochemical content, antioxidant, anticancer, immunomodulatory, and antigenotoxic activities of lemon, grapefruit, and mandarin citrus peels
    Author: KAE Diab
    Year: 2016

 

  • Title: In vivo comparative studies on antigenotoxicity of date palm (Phoenix dactylifera L.) pits extract against DNA damage induced by N-Nitroso-N-methylurea in mice
    Author: KA Diab, EI Aboul-Ela
    Year: 2012

 

  • Title: Carbon tetrachloride induced hepato/renal toxicity in experimental mice: antioxidant potential of Egyptian Salvia officinalis L essential oil
    Author: MA Fahmy, KA Diab, NS Abdel-Samie, EA Omara, ZM Hassan
    Year: 2018

 

  • Title: Genotoxicity of carbon tetrachloride and the protective role of essential oil of Salvia officinalis L. in mice using chromosomal aberration, micronuclei formation, and …
    Author: KAE Diab, MA Fahmy, ZM Hassan, EM Hassan, AB Salama, EA Omara
    Year: 2018

 

  • Title: Inhibitory activity of black mulberry (Morus nigra) extract against testicular, liver and kidney toxicity induced by paracetamol in mice
    Author: KA Diab, MA Fahmy, EM Hassan, ZM Hassan, EA Omara, …
    Year: 2020

 

  • Title: The impact of the low frequency of the electromagnetic field on human
    Author: KA Diab
    Year: 2020

 

  • Title: Inhibitory activity of flaxseed oil against CdCl2 induced liver and kidney damage: Histopathology, genotoxicity, and gene expression study
    Author: KA Diab, NE Ibrahim, MA Fahmy, EM Hassan, EA Omara
    Year: 2020

🏆 Conclusion

Dr. Kawthar Diab’s journey from an aspiring zoologist to a distinguished Research Professor in Genetics and Cytology is a testament to her unwavering commitment to scientific discovery. Her work not only enhances our understanding of genetic toxicology but also paves the way for integrating traditional medicinal knowledge with modern genetic research. As she continues to push the boundaries of genetic science, her contributions remain invaluable to both academia and global health advancements.

Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Posted on by Neuroscientists

Mr.Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Mr. Hamid khan Icahn School of Medicine at Mount Sinai, New York Pakistan

Hamid Khan is a dedicated researcher and educator who recently completed his PhD in Biotechnology, specializing in Human Molecular Genetics. His academic journey includes a strong foundation in biological sciences, evidenced by his educational background ranging from a BSc to a PhD, with a focus on genetic analysis of rare congenital disorders. His doctoral research has provided insights into the genetic basis of autism spectrum disorder (ASD) and oculocutaneous albinism, contributing significantly to the understanding of these conditions.

profile

scholar

🎓 Education

PhD in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan & University of Toronto, Canada (2018-2024).MS/M.Phil in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan (2016-2018).M.Sc in ZoologyHazara University Mansehra, KPK, Pakistan (2011-2013).B.Sc in Biological Science (Botany, Zoology, Chemistry)University of Peshawar, Pakistan (2008-2010).H.S.S.C Pre-Medical
Peshawar Board, Pakistan (2006-2008)S.S.C Science SubjectsPeshawar Board, Pakistan (2004-2006).B.Ed in Education
Sarhad University of Science & Information Technology (2014).CT Certified TeacherAllama Iqbal Open University (2016).

🔬 Research Experience

Researcher at Biomolecular Genetic Engineering Lab, International Islamic University Islamabad (4 years).Research Associate in Pak-US Science and Technology Cooperation Program (1 year).Researcher in MiND Laboratory, Campbell Family Mental Health Research Institute, Toronto, Canada (6 months)

💼 Work Experience

Visiting Lecturer at Department of Biological Sciences, IIUI (3 years).Lecturer at IQRA College of Technology, IIUI (2 years)

 

🛠️ Skills

Laboratory Skills: PCR, NGS data analysis, Microarray, Gene Cloning, Cell Culturing, etc.Computer Skills: Python, Sentieon, Verseq, Exomiser, Excel, PowerPoint, Word.

🏆 Awards

IRSIP Award from the Higher Education Commission (HEC) Pakistan.First position holder in PhD coursework.Selected as Research Associate in a Pak-US project.

🌍 Collaborations

Currently working with three international and several national collaborations.

📚 Publications

  1. Title: Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder
    Authors: Hamid Khan, Ricardo Harripaul, Anna Mikhailov, Sumayah Herzi, …
    Year: 2024

 

  1. Title: Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder
    Authors: Lettie E Rawlins, Reza Maroofian, Stuart J Cannon, Muhannad Daana, Mina Zamani, Shamsul Ghani, …
    Year: 2024

 

  1. Title: Nigella sativa extract abrogates traumatic brain injury-induced memory impairment in adult mice
    Authors: RU Khan, SM Jawad, MM Kiyani, SA Shah, S Bashir, Hamid Khan
    Year: 2024

 

  1. Title: Mutational spectrum associated with oculocutaneous albinism and Hermansky-Pudlak syndrome in nine Pakistani families
    Authors: J Khan, S Asif, S Ghani, Hamid Khan, MW Arshad, SA Khan, S Lin, EL Baple, …
    Year: 2024

 

  1. Title: An Update on Recent Advancement in Autism Spectrum Disorder Treatment Strategies
    Authors: Hamid Khan, M Uzair, H Riaz, B Khan, MI Shabbir
    Year: 2023

Conclusion

Hamid Khan’s profile illustrates a strong commitment to advancing the field of biotechnology through research and education. His focus on the genetic underpinnings of rare disorders positions him as a valuable contributor to both academic and clinical settings. With a proven track record of research publications and collaborative projects, he is poised to make significant impacts in the realm of human genetics and molecular biology. His dedication to teaching and nurturing student curiosity further underscores his potential as an educator and mentor. As he seeks new opportunities, his combination of technical expertise, research experience, and passion for education will undoubtedly enable him to excel and inspire in any dynamic academic or research environment.